4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-007559
Senior VP, Chief Pharma Dev. acquired 1,419 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-01-23 | Grant or award | +1,419 | 6,536 | D | ||
| Derivatives | |||||||
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-01-23 | Grant or award · Stock Option (Right to Buy) | +2,138 | 2,138 | D | ||
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-01-23 | Grant or award · Market Stock Unit | +1,419 | 1,419 | D | ||
Loading xslF345X05/ownership.xml…